10X Genomics Signs Asia-Pacific Distribution Deals
News May 17, 2016
10x Genomics, Inc. has announced that it has entered into distribution agreements with MDxK, Inc., Millennium Science Pty Ltd, Research Instruments Pte Ltd, and Star Research Technology Ltd., for the promotion, sales, and support of 10x’s Chromium™ System and associated products to address long range and single cell genomic applications in Asia and Pacific Rim markets (APAC). The distribution agreements cover South Korea (MDxK), Australia and New Zealand (Millennium Science), Southeast Asia (Research Instruments), and China (Star Research Technology).
“The Asia-Pacific region is experiencing significant growth across all areas of genomics spurring demand for solutions that provide full sequence information and genomic analysis at single cell resolution,” said Dr. Serge Saxonov, 10x’s Chief Executive Officer, “we are thrilled to welcome Millennium Science, MDxK, Research Instruments, and Star Research Technology, each premier life science instrumentation distributors in their respective regions, as key partners to 10x. These partnerships represent an important step in the global commercial expansion of 10x, and working together, we will be able to better serve our customers' needs in the Asia-Pacific region.”
10x’s microfluidics-based molecular barcoding solutions, built on the proprietary GemCode™ Technology, provide researchers critical long-range sequence information through existing sequencing workflows. The Chromium Genome and Exome Solutions together include phasing, structural variant analysis, de novo genome assembly, and remapping of difficult regions of the genome. In addition, 10x’s recently introduced Chromium Single Cell Solution allows for rapid and comprehensive analysis of dynamic transcription events from large numbers of individual cells.
“We are excited to be working with 10x to bring the Chromium System to market and introduce important new dimensions to our customers’ research”, said Steven Qiu, Chief Executive Officer of Star Research Technology. “10x Genomics is recognized for delivering critical enabling applications, including long-range sequence information and high-throughput single cell analysis. This partnership will enable our NGS customers to access 10x’s linked-read sequencing products and significant new capabilities that will power further advances in single cell biology and genomic research.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE